Full Breakdown
Surge in Laboratory Monkey Prices Driven by China's Biotech Boom
2/18/2026, 10:48:44 PM
Rising Costs of Laboratory Monkeys
The cost of laboratory monkeys in China has surged to approximately 140,000 yuan (US$20,260), surpassing the nation's average annual wage. This increase reflects a doubling of prices over the past five years, primarily driven by a significant uptick in drug research and development activities. Official government procurement records indicate that the demand for cynomolgus macaques, essential for preclinical drug testing, has intensified due to a wave of drug-licensing agreements between Chinese biotech firms and international pharmaceutical companies.
Factors Behind the Price Surge
Analysts attribute the soaring costs to a combination of factors, including a revival in pharmaceutical fundraising and an unprecedented number of candidate drugs entering early-stage testing. For instance, a public tender released by the Shanghai Institute of Materia Medica in February 2023 outlined a budget of 62 million yuan for 450 cynomolgus macaques, translating to about 137,800 yuan per animal. This price is slightly lower than the 170,000 yuan paid by the National Institutes for Food and Drug Control for its first batch of monkeys in 2023, a purchase influenced by heightened demand for primates during Covid-19 vaccine and drug trials.
Impact on Drug Development
The rising costs of laboratory monkeys pose potential implications for drug development in China. As noted by Cui Cui, head of healthcare research for Asia at Jefferies, "US rate cuts have boosted biotech funding, so more projects are moving into early stages and need safety assessment – and that means more monkeys." This trend suggests that while the increased funding may accelerate drug development, it also raises concerns about the sustainability of sourcing laboratory animals at such high prices.
Criticism and Opposition
Despite the growth in the biotech sector, there are concerns regarding the ethical implications of using primates for research. Critics argue that the rising prices may lead to increased pressure on suppliers, potentially compromising animal welfare standards. Additionally, the reliance on primates for drug testing raises questions about the ethical considerations of animal use in scientific research.
Conflicting Reports & Gaps
While the reported price of 140,000 yuan for laboratory monkeys reflects current market trends, there is a lack of comprehensive data on the long-term sustainability of such pricing. Furthermore, discrepancies exist regarding the exact number of monkeys required for ongoing and future drug trials, which could impact pricing and availability.
Verbatim Quotes
- “US rate cuts have boosted biotech funding, so more projects are moving into early stages and need safety assessment – and that means more monkeys,” — Cui Cui, Head of Healthcare Research for Asia, Jefferies
The rapid increase in laboratory monkey prices in China underscores the intersection of biotechnology advancements and ethical considerations in drug development, highlighting the need for ongoing dialogue about animal welfare in research practices.
